Comparison of Dosimetric and Biologic Effective Dose Parameters for Prostate and Urethra Using 131Cs and 125I for Prostate Permanent Implant Brachytherapy

« Previous Next »International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 1 , Pages 247-254, 1 September 2008

Comparison of Dosimetric and Biologic Effective Dose Parameters for Prostate and Urethra Using ¹³¹Cs and ¹²⁵I for Prostate Permanent Implant Brachytherapy

Arjun Sahgal, M.D.
- Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA
- Department of Radiation Oncology, Odette Cancer Centre at Sunnybrook Hospital, University of Toronto, Toronto, ON, Canada
Siavash Jabbari, M.D.
- Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA
Josephine Chen, Ph.D.
- Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA
Barbie Pickett, Ph.D.
- Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA
Mack Roach III, M.D.
- Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA
Vivian Weinberg, Ph.D.
- University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center Biostatistics Core, San Francisco, CA
I-Chow Hsu, M.D.
- Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA
Jean Pouliot, Ph.D.
- Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA
- Reprint requests to: Jean Pouliot, Ph.D., Department of Radiation Oncology, University of California, San Francisco, School of Medicine, 1600 Divisadero St., Suite H1031, San Francisco, CA 94143. Tel: (415) 353-8900; Fax: (415) 353-8679